EMPG
EMPG
Empro Group Inc. Ordinary sharesIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2024 | $108.66K ▲ | $4.59M ▲ | $3.06M ▲ | $1.53M ▲ |
| Q2-2024 | $38.22K ▼ | $2.86M ▼ | $2.43M ▼ | $430.83K ▼ |
| Q4-2023 | $283.16K | $3.78M | $3.04M | $741.21K |
What's financially strong about this company?
Shareholder equity and retained earnings soared this quarter, and the company has no goodwill or intangible risk. Debt is moderate and falling, and most assets are high quality and tangible.
What are the financial risks or weaknesses?
Receivables and payables both ballooned, suggesting customers are paying slower and the company is delaying its own bills. Cash is still low compared to short-term needs, so liquidity could get tight if collections don't improve.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|
5-Year Trend Analysis
A comprehensive look at Empro Group Inc. Ordinary shares's financial evolution and strategic trajectory over the past five years.
Key strengths include the ability to generate attractive margins and strong cash flow in good years, a growing equity base, and a balance sheet free from large, potentially overstated intangibles. On the commercial side, EMPG benefits from recognized brands, differentiated products, and a multi-channel distribution footprint across physical retail and online platforms. Its willingness to innovate in both healthcare and beauty has created a diversified product mix that is not dependent on a single hero item or geography.
Main risks center on volatility and financial resilience. Revenue, earnings, and cash flow have all swung sharply, highlighting exposure to demand shocks and working capital management challenges. Rising leverage, shrinking cash reserves, and reliance on receivables weaken short-term financial flexibility. Competitive risk is also significant: the company operates in crowded markets with powerful global brands and agile local competitors, where continued spending on innovation and marketing is required just to maintain position.
Looking ahead, EMPG’s prospects hinge on its ability to stabilize its financial performance while continuing to innovate and expand. If it can translate its recent margin improvements and product successes into more consistent revenue and cash generation, the business could gradually strengthen its balance sheet and reinvest for growth. Conversely, any renewed downturn in demand, missteps in managing working capital, or slowdown in product innovation could quickly strain its more leveraged and less liquid current position. The path forward appears balanced between meaningful opportunity and equally meaningful execution risk.
About Empro Group Inc. Ordinary shares
https://empro.myMalaysian beauty & personal care brand, evolving from eyebrow embroidery into cosmetics, skincare, and healthcare products, distributing across Southeast Asia and Europe.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2024 | $108.66K ▲ | $4.59M ▲ | $3.06M ▲ | $1.53M ▲ |
| Q2-2024 | $38.22K ▼ | $2.86M ▼ | $2.43M ▼ | $430.83K ▼ |
| Q4-2023 | $283.16K | $3.78M | $3.04M | $741.21K |
What's financially strong about this company?
Shareholder equity and retained earnings soared this quarter, and the company has no goodwill or intangible risk. Debt is moderate and falling, and most assets are high quality and tangible.
What are the financial risks or weaknesses?
Receivables and payables both ballooned, suggesting customers are paying slower and the company is delaying its own bills. Cash is still low compared to short-term needs, so liquidity could get tight if collections don't improve.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|
5-Year Trend Analysis
A comprehensive look at Empro Group Inc. Ordinary shares's financial evolution and strategic trajectory over the past five years.
Key strengths include the ability to generate attractive margins and strong cash flow in good years, a growing equity base, and a balance sheet free from large, potentially overstated intangibles. On the commercial side, EMPG benefits from recognized brands, differentiated products, and a multi-channel distribution footprint across physical retail and online platforms. Its willingness to innovate in both healthcare and beauty has created a diversified product mix that is not dependent on a single hero item or geography.
Main risks center on volatility and financial resilience. Revenue, earnings, and cash flow have all swung sharply, highlighting exposure to demand shocks and working capital management challenges. Rising leverage, shrinking cash reserves, and reliance on receivables weaken short-term financial flexibility. Competitive risk is also significant: the company operates in crowded markets with powerful global brands and agile local competitors, where continued spending on innovation and marketing is required just to maintain position.
Looking ahead, EMPG’s prospects hinge on its ability to stabilize its financial performance while continuing to innovate and expand. If it can translate its recent margin improvements and product successes into more consistent revenue and cash generation, the business could gradually strengthen its balance sheet and reinvest for growth. Conversely, any renewed downturn in demand, missteps in managing working capital, or slowdown in product innovation could quickly strain its more leveraged and less liquid current position. The path forward appears balanced between meaningful opportunity and equally meaningful execution risk.
CEO
Chee Wei Yeoh